Aoxin Q & M Dental Group (SGX:1D4) 10-Year Sharpe Ratio: N/A (As of Jun. 24, 2026)


SGX:1D4 Aoxin Q & M Dental Group Ltd SGX:1D4
56 GF Score
Price S$0.24
GF Value S$0.05
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Aoxin Q & M Dental Group 10-Year Sharpe Ratio?

The 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. As of today (2026-06-24), Aoxin Q & M Dental Group's 10-Year Sharpe Ratio is Not available.


Aoxin Q & M Dental Group  (SGX:1D4) 10-Year Sharpe Ratio Explanation

The 10-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past ten years. It is calculated as the annualized result of the average ten-year monthly excess returns divided by its standard deviation in the ten-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Aoxin Q & M Dental Group 10-Year Sharpe Ratio Related Terms


SGX:1D4 vs HCA, THC, DVA: 10-Year Sharpe Ratio Comparison

For the Medical Care Facilities subindustry, Aoxin Q & M Dental Group's 10-Year Sharpe Ratio, along with its competitors' market caps and 10-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aoxin Q & M Dental Group 10-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aoxin Q & M Dental Group's 10-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Aoxin Q & M Dental Group's 10-Year Sharpe Ratio falls into.


SGX:1D4
56GF Score
Aoxin Q & M Dental Group Ltd SGX:1D4
10-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aoxin Q & M Dental Group 10-Year Sharpe Ratio Calculation

The 10-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last ten years. A stock / portfolio's 10-Year Sharpe Ratio can be calculated by dividing the difference between the ten-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past ten years.

Is Aoxin Q & M Dental Group (SGX:1D4) Overvalued in 2026?

Based on GuruFocus' analysis, Aoxin Q & M Dental Group stock appears to be overvalued. The current stock price of S$0.24 is trading 370% above its estimated GF Value™ of S$0.05. GuruFocus considers Aoxin Q & M Dental Group to be Significantly Overvalued.

Key valuation signals for SGX:1D4:

  • 10-Year Sharpe Ratio: N/A
  • GF Value™: S$0.05 vs. price of S$0.24 (370% above fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the SGX:1D4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aoxin Q & M Dental Group Business Description

Address 9 Raffles Place, No. 26-01, Republic Plaza, Singapore, SGP, 048619
Aoxin Q & M Dental Group Ltd, along with its subsidiaries, offers private dental services, dental equipment, and supplies. The various dental care services offered by the Group include Stomatology and general dentistry, Endodontics, Orthodontics, Periodontics, Dental implantology, and many more. Its dental equipment and supplies portfolio includes dental chairs, ultrasound scanners, dental instruments, materials, and consumables for dental hospitals, clinics, distributors, and laboratories. The Group's reportable operating segments are: Primary healthcare, which generates the maximum revenue, Distribution of dental equipment and supplies, and Laboratory services. Geographically, it generates maximum revenue from the People's Republic of China (PRC) and the rest from Singapore.
56GF Score

Get the complete analysis for SGX:1D4

10-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.24
Price
S$0.05
GF Value